4.4 Article

Aldosterone deficiency adversely affects pregnancy outcome in mice

Journal

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
Volume 464, Issue 4, Pages 331-343

Publisher

SPRINGER
DOI: 10.1007/s00424-012-1145-4

Keywords

Aldosterone; Placenta; Fetal growth; Systolic blood pressure; High-salt diet

Categories

Funding

  1. Zurich Center for Integrative Human Physiology (ZIHP)
  2. Swiss National Science Foundation [310030-122243, 31003A_138143/1, 3200030_135596/1]
  3. Swiss National Centre of Competence in Research Kidney.CH
  4. Swiss National Science Foundation (SNF) [31003A_138143, 310030-122243] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

Circulating aldosterone levels are increased in human pregnancy. Inadequately low aldosterone levels as present in preeclampsia, a life-threatening disease for both mother and child, are discussed to be involved in its pathogenesis or severity. Moreover, inactivating polymorphisms in the aldosterone synthase gene have been detected in preeclamptic women. Here, we used aldosterone synthase-deficient (AS(-/-)) mice to test whether the absence of aldosterone is sufficient to impair pregnancy or even to cause preeclampsia. AS(-/-) and AS(+/+) females were mated with AS(+/+) and AS(-/-) males, respectively, always generating AS(+/-) offspring. With maternal aldosterone deficiency in AS(-/-) mice, systolic blood pressure was low before and further reduced during pregnancy with no increase in proteinuria. Yet, AS(-/-) had smaller litters due to loss of fetuses as indicated by a high number of necrotic placentas with massive lymphocyte infiltrations at gestational day 18. Surviving fetuses and their placentas from AS(-/-) females were smaller. High-salt diet before and during pregnancy increased systolic blood pressure only before pregnancy in both genotypes and abolished the difference in blood pressure during late pregnancy. Litter size from AS(-/-) was slightly improved and the differences in placental and fetal weights between AS(+/+) and AS(-/-) mothers disappeared. Overall, an increased placental efficiency was observed in both groups paralleled by a normalization of elevated HIF1 alpha levels in the AS(-/-) placentas. Our results demonstrate that aldosterone deficiency has profound adverse effects on placental function. High dietary salt intake improved placental function. In this animal model, aldosterone deficiency did not cause preeclampsia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Physiology

Expression of phosphate and calcium transporters and their regulators in parotid glands of mice

Seraina O. Moser, Betuel Haykir, Catharina J. Kueng, Carla Bettoni, Nati Hernando, Carsten A. Wagner

Summary: The concentration of inorganic phosphate in plasma is controlled by hormones, and saliva glands have the ability to concentrate phosphate. The parotid glands preferentially use Slc20 for phosphate transport and are potential targets for regulation by PTH and vitamin D-3.

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2023)

Editorial Material Physiology

Smart kidneys: Enhance intratubular communication to overcome disease

Carsten A. Wagner

ACTA PHYSIOLOGICA (2023)

Article Medicine, General & Internal

Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial

Nilufar Mohebbi, Alexander Ritter, Anna Wiegand, Nicole Graf, Suzan Dahdal, Daniel Sidler, Spyridon Arampatzis, Karine Hadaya, Thomas F. Mueller, Carsten A. Wagner, Rudolf P. Wuethrich

Summary: This study examined the effects of sodium bicarbonate treatment on graft function in kidney transplant recipients. The results showed that treatment with sodium bicarbonate for two years did not affect the decline in estimated glomerular filtration rate (GFR). Therefore, sodium bicarbonate treatment is not generally recommended for preserving GFR in kidney transplant recipients with chronic kidney disease and metabolic acidosis.

LANCET (2023)

Editorial Material Transplantation

The need for a multi-disciplinary reflection about frailty and cognitive impairment in chronic kidney disease

Michele Farisco, Irene Zecchino, Giovambattista Capasso, CONNECT Consortium

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Biochemistry & Molecular Biology

The phytase RipBL1 enables the assignment of a specific inositol phosphate isomer as a structural component of human kidney stones

Guizhen Liu, Esther Riemer, Robin Schneider, Daniela Cabuzu, Olivier Bonny, Carsten A. A. Wagner, Danye Qiu, Adolfo Saiardi, Annett Strauss, Thomas Lahaye, Gabriel Schaaf, Thomas Knoll, Jan P. P. Jessen, Henning J. J. Jessen

Summary: The analysis of Inositol phosphates (InsPs), which are present in all eukaryotes, is challenging due to the presence of numerous different phosphate ester isomers. Researchers used capillary electrophoresis coupled to electrospray ionization mass spectrometry (CE-ESI-MS) to analyze InsP(2) and InsP(3) and discovered new InsP(3) isomers. For the first time, specific and abundant InsP(3) isomers, namely Ins(1,2,3)P-3, Ins(1,2,6)P-3, and/or Ins(2,3,4)P-3, were found in urine and kidney stones in human samples.

RSC CHEMICAL BIOLOGY (2023)

Review Biochemistry & Molecular Biology

The mechanisms of alkali therapy in targeting renal diseases

Pedro Henrique Imenez Silva, Donald E. Wesson, Carsten A. Wagner

Summary: Chronic kidney disease (CKD) is a disease characterized by progressive decline in kidney function. Treatments that aim to stabilize or slow its progression can delay the need for kidney replacement therapy and reduce the mortality rate associated with reduced kidney function. Metabolic acidosis and less severe stages of the acid stress continuum are common in CKD, and studies have shown that correcting these conditions can slow the progression to end-stage kidney disease. This correction can be achieved through dietary changes, such as consuming fewer acid-producing foods or more base-producing foods, or through the use of mineral alkali or pharmacological approaches.

BIOCHEMICAL SOCIETY TRANSACTIONS (2023)

Review Clinical Neurology

Cognitive disorders in patients with chronic kidney disease: Approaches to prevention and treatment

Marion Pepin, Aleksandra Klimkowicz-Mrowiec, Olivier Godefroy, Pilar Delgado, Sol Carriazo, Ana Carina Ferreira, Aleksandra Golenia, Jolanta Malyszko, Tomasz Grodzicki, Konstantinos Giannakou, Giuseppe Paolisso, Michelangela Barbieri, Liliana Garneata, Carmen Antonia Mocanu, Sophie Liabeuf, Goce Spasovski, Carmine Zoccali, Annette Bruchfeld, Ana Farinha, Mustafa Arici, Giovambattista Capasso, Andrzej A. Wiecek, Ziad Massy

Summary: Cognitive impairment is common in patients with chronic kidney disease (CKD). This article reviews interventions for the complications of CKD and prevention of vascular events, which may potentially also be protective against cognitive impairment. Nonpharmacological and pharmacological methods to prevent cognitive impairment and/or minimize its impact on CKD patients' daily lives are discussed. It is necessary to conduct studies assessing the effect of interventions on the cognitive function of patients with CKD.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Review Urology & Nephrology

The pathophysiology of distal renal tubular acidosis

Carsten A. Wagner, Robert Unwin, Sergio C. Lopez-Garcia, Robert Kleta, Detlef Bockenhauer, Stephen Walsh

Summary: This review discusses the underlying genetic and acquired causes of distal renal tubular acidosis (dRTA), a condition characterized by the failure to acidify urine below pH 5.5. Inherited forms of dRTA are caused by variants in specific genes such as SLC4A1 and ATP6V1B1, while acquired forms can result from autoimmune diseases or adverse drug effects. Incomplete dRTA, which is frequently found in patients with or without kidney stone disease, may represent an intermediate state in the ability to excrete acids. Untreated or unrecognized dRTA can lead to various complications such as rickets, osteomalacia, nephrolithiasis, and electrolyte disorders, and increase the risk of chronic kidney disease development.

NATURE REVIEWS NEPHROLOGY (2023)

Article Multidisciplinary Sciences

The AE4 transporter mediates kidney acid-base sensing

H. Vitzthum, M. Koch, L. Eckermann, S. L. Svendsen, P. Berg, C. A. Huebner, C. A. Wagner, J. Leipziger, C. Meyer-Schwesinger, H. Ehmke

Summary: Maintaining acid-base balance is important for the kidneys, and the solute transporter AE4 in beta-intercalated cells is found to play a role in renal acid-base sensing mechanism.

NATURE COMMUNICATIONS (2023)

Article Urology & Nephrology

Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients

Daniela Egli-Spichtig, Ahmad Kamal Hamid, Eva Maria Pastor Arroyo, Markus Ketteler, Andrzej Wiecek, Alexander R. Rosenkranz, Andreas Pasch, Horst Lorenz, Burkhard Hellmann, Michael Karus, Richard Ammer, Isabel Rubio-Aliaga, Carsten A. Wagner

Summary: This study aimed to assess the effects of combined treatment with nicotinamide modified release (NAMR) and phosphate binders (PB) on serum phosphate, FGF23, inflammation, and iron metabolism in ESKF patients. The results showed that iFGF23 was a better predictor of serum phosphate changes induced by NAMR and PB treatment. Furthermore, serum phosphate and iPTH were the best predictors of FGF23. These findings suggest that lowering serum phosphate in ESKF patients may highly depend on iFGF23.

CLINICAL KIDNEY JOURNAL (2023)

Article Medicine, Research & Experimental

Ovarian cancer G protein-coupled receptor 1 deficiency exacerbates crystal deposition and kidney injury in oxalate nephropathy in female mice

Nima Yassini, Janine Sprenger, Eva Maria Pastor Arroyo, Christiane Krudewig, Giovanni Pellegrini, Nicole Joller, Carsten A. Wagner, Pedro Henrique Imenez Silva

Summary: Ovarian cancer G protein-coupled receptor 1 (OGR1) and G protein-coupled receptor 4 (GPR4) play important roles in renal acid-base physiology, tissue inflammation, and fibrosis. In this study, the researchers found that OGR1 deficiency led to increased crystal deposition and impaired kidney function in mice with crystalline nephropathy. On the other hand, GPR4 deficiency did not have a significant impact on disease progression. These findings suggest that OGR1 may be important in limiting kidney crystal deposition and could be relevant to the pathophysiology of kidney stones.

CLINICAL SCIENCE (2023)

Article Endocrinology & Metabolism

Blocking FGF23 signaling improves the growth plate of mice with X-linked hypophosphatemia

Rocio Fuente, Eva-Maria Pastor-Arroyo, Nicole Gehring, Patricia Oro Carbajosa, Laura Alonso-Duran, Ivan Zderic, James Tapia-Dean, Ahmad Kamal Hamid, Carla Bettoni, Fernando Santos, Carsten A. Wagner, Isabel Rubio-Aliaga

Summary: This study examines the role of FGF23 signaling in growth plate metabolism and finds that a short C-terminal FGF23 fragment and modified peptides can improve growth and bone issues in XLH patients, enhancing growth rate and growth plate structure.

JOURNAL OF ENDOCRINOLOGY (2023)

Review Urology & Nephrology

Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor

Sophie Liabeuf, Vesna Pesic, Goce Spasovski, Romaldas Maciulaitis, Mickael Bobot, Ana Farinha, Carsten A. Wagner, Robert J. Unwin, Giovambattista Capasso, Inga Arune Bumblyte, Gaye Hafez

Summary: People with CKD often suffer from mild cognitive impairment and other neurocognitive disorders. Adverse drug reactions may contribute to cognitive impairment in CKD, especially due to polypharmacy and the impact of reduced kidney function and dialysis. Understanding and managing these risks is important for improving patient outcomes.

CLINICAL KIDNEY JOURNAL (2023)

Article Physiology

PCK1 is a key regulator of metabolic and mitochondrial functions in renal tubular cells

Thomas Verissimo, Delal Dalga, Gregoire Arnoux, Imene Sakhi, Anna Faivre, Hannah Auwerx, Soline Bourgeois, Deborah Paolucci, Quentin Gex, Joseph M. Rutkowski, David Legouis, Carsten A. Wagner, Andrew M. Hall, Sophie de Seigneux

Summary: Phosphoenolpyruvate carboxykinase 1 (PCK1) plays an important role in maintaining normal tubular physiology, lactate, and glucose homeostasis in the kidney. It regulates acid-base balance and ammoniagenesis. Downregulation of PCK1 during renal injury impairs renal function, making it a potential therapeutic target in renal disease.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2023)

Article Urology & Nephrology

The B1 H+-ATPase (Atp6v1b1) Subunit in Non-Type A Intercalated Cells is Required for Driving Pendrin Activity and the Renal Defense Against Alkalosis

Soline Bourgeois, Jana Kovacikova, Milica Bugarski, Carla Bettoni, Nicole Gehring, Andrew Hall, Carsten A. Wagner

Summary: This study reveals the critical role of H+-ATPases in the function of non-type A intercalated cells (ICs) in protecting against alkalosis. It also highlights the previously unrecognized need for the basolateral B1 isoform for proper assembly and stimulation of H+-ATPase complexes.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

No Data Available